Jallorina A, Vij K, Wan L, Thomas J, et al. A Decadal Exploration of Cutaneous Adverse Effects of FDA-Approved Cardiovascular Medications: Insights from 2013 to 2023. J Cardiovasc Pharmacol 2024 Dec 5. doi: 10.1097/FJC.0000000000001660.
PMID: 39636124